Northwest Biotherapeutics, Inc. (NWBO) reported the earnings of $-0.88/Share in the last quarter where the estimated EPS by analysts was $-0.39/share. The difference between the expected and actual EPS was $-0.49/share, which represents an Earnings surprise of -125.6%.
Some buy side analysts are also providing their Analysis on Northwest Biotherapeutics, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Northwest Biotherapeutics, Inc. might touch $5 high while the Average Price Target and Low price Target is $5 and $5 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Northwest Biotherapeutics, Inc. got Downgrade on 12-Mar-14 where investment firm Oppenheimer Downgrade the stock from Outperform to Perform.
Northwest Biotherapeutics, Inc. closed its last trading session at $0.36 with the loss of -33.68%. The Market Capitalization of the company stands at 36.53 Million. The Company has 52-week high of $1.84 and 52-week low of $0.22. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -37.45% where SMA50 and SMA200 are -40.65% and -49.72% respectively. The Company Touched its 52-Week High on Apr 7, 2016 and 52-Week Low on Mar 17, 2017.
The Relative Volume of the company is 8.45 and Average Volume (3 months) is 1.31 million. Northwest Biotherapeutics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Northwest Biotherapeutics, Inc. currently shows a Weekly Performance of -37.34%, where Monthly Performance is -47.1%, Quarterly performance is -71.31%, 6 Months performance is -43.32% and yearly performance percentage is -81.82%. Year to Date performance value (YTD perf) value is -31.6%. The Stock currently has a Weekly Volatility of 10.61% and Monthly Volatility of 9.03%.